An outbreak of an antibiotic-resistant infection has been declared at a major hospital in Northern Ireland. The Belfast Trust confirmed it is collaborating with the Public Health Agency to manage the spread of a Carbapenemase-Producing Organism (CPO) at the Royal Victoria Hospital.
What is a CPO?
CPOs are highly resistant bacteria that produce enzymes capable of breaking down carbapenem antibiotics, which are often used as a last resort. The infection spreads from person to person through contact with contaminated hands, medical equipment, or surfaces.
Timeline of the Outbreak
The first case was identified on April 28, and the outbreak was formally declared two days later on April 30. Patients who have previously taken multiple courses of antibiotics are at higher risk of carrying a CPO.
Control Measures Implemented
Enhanced cleaning and strict infection control protocols have been introduced at the hospital. The Trust is working closely with the Public Health Agency and has been engaging with families of affected patients. Those testing positive for CPO will be isolated in single rooms with en-suite facilities or a commode. Staff must wear gloves and aprons or gowns when providing care.
Official Statement
A Belfast Trust spokesperson stated: "Belfast Trust is managing an outbreak of a Carbapenemase-Producing Organism (CPO) at the Royal Victoria Hospital with support from the Public Health Agency on infection, prevention and control guidance. A small number of patients within the Medical Specialities and Unscheduled Care Division have been identified as carrying a CPO. The first case was identified on 28 April 2026, and the outbreak was formally declared on 30 April 2026. Appropriate outbreak control measures, including enhanced cleaning of the ward, have been implemented in line with guidance from the Outbreak Control Group. The Trust is engaging with the families of all affected patients. There have been no reported fatalities or serious illness directly attributed to this specific CPO strain."
